European <scp>EADV</scp> network on assessment of severity and burden of Pruritus (PruNet): first meeting on outcome tools

Ständer, Sonja; Zeidler, Claudia; Riepe, Claudia; Steinke, Sabine; Bruland, Philipp; Soto-Rey, Iñaki; Storck, Michael; Agner, Tove; Augustin, Matthias; Blome, Christine; Dalgard, Florence; Evers, Andrea W M; Garcovich, Simone; Gonçalo, Margarida; Lambert, Julien; Legat, Franz J.; Leslie, Tabi A.; Miséry, Laurent; Raap, Ulrike; Reich, Adam; Şavk, Ekin; Streit, Markus; Serra‐Baldrich, E.; Szepietowski, Jacek C.; Wallengren, Joanna; Weißhaar, Elke; Dugas, Martin

doi:10.1111/jdv.13296

Cited by 46 publications

(55 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Moreover, in the multivariate model, the DLQI had a significant effect on the therapeutic needs. Until the role of the DLQI has been verified, more pruritus‐specific QoL measurement tools, for example the comprehensive ItchyQoL, should be preferably used in patients with CP . Secondly, further qualitative and quantitative investigations on the PBI‐P could help to elicit more detailed information about patients’ understanding of treatment goal items.…”

Section: Discussionmentioning

confidence: 99%

Chronic pruritus: evaluation of patient needs and treatment goals with a special regard to differences according to pruritus classification and sex

et al. 2017

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Chronic pruritus: evaluation of patient needs and treatment goals with a special regard to differences according to pruritus classification and sex

et al. 2017

Self Cite

View full text Add to dashboard Cite

show abstract

“…In der Praxis hat sich zur Verlaufsbeurteilung die Erfassung der subjektiven Pruritusintensität bewährt und zur regelmäßigen Erfassung des Symptoms wird eine visuelle Analogskala (VAS), numerische Ratingskala (NRS) oder verbale Ratingskala (VRS) empfohlen [12][13][14].…”

Section: Empfehlungunclassified

S2k Guidelines for the diagnosis and treatment of chronic pruritus – update – short version

Ständer¹,

Zeidler²,

Augustin

et al. 2017

J Deutsche Derma Gesell

View full text Add to dashboard Cite

Associated with a host of different diseases, pruritus is a cardinal symptom that poses an interdisciplinary diagnostic and therapeutic challenge. Over time, that symptom may progress independently of the initial cause, thus losing its function as a warning sign and turning into a clinically relevant disease of its own. In Germany, approximately 13.5 % of the general population are affected by chronic pruritus, with an incidence of 7 %. All forms of chronic pruritus require targeted treatment consisting of (a) diagnosis and management of the underlying disease, (b) dermatological treatment of primary or secondary (for example, dry skin, scratch lesions) symptoms, (c) symptomatic antipruritic treatment, and (d) psychological/psychotherapeutic treatment in case of an underlying or associated psychological or psychosomatic condition. Medical care of patients with chronic pruritus should therefore include an interdisciplinary approach, in particular with respect to diagnosis and therapy of the underlying disease as well as in terms of the management of treatment and adverse events. The objective of the present interdisciplinary guidelines is to define and standardize diagnostic and therapeutic procedures in patients with chronic pruritus. This is a short version of the current S2 guidelines on chronic pruritus. The long version may be found at www.awmf.org.

show abstract

“…The European Network on Assessment of Severity and Burden of Pruritus (PruNet) was founded in 2014 in order to validate and harmonize pruritus assessment tools for routine care and RCTs across Europe . Before its founding, methods to assess and interpret pruritus in clinical health care and RCTs varied in each country making useful comparisons of patient treatments unfeasible.…”

Section: Introductionmentioning

confidence: 99%

Cross‐European validation of the ItchyQoL in pruritic dermatoses

Zeidler

Steinke

Riepe

et al. 2018

Acad Dermatol Venereol

Self Cite

View full text Add to dashboard Cite

show abstract

European EADV network on assessment of severity and burden of Pruritus (PruNet): first meeting on outcome tools

Abstract: The validation and harmonization of standards are needed for the improvement of quality care for patients suffering from pruritic dermatoses. This summer, the first validation studies in several EADV member countries already began.

Cited by 46 publications

References 8 publications

Chronic pruritus: evaluation of patient needs and treatment goals with a special regard to differences according to pruritus classification and sex

Chronic pruritus: evaluation of patient needs and treatment goals with a special regard to differences according to pruritus classification and sex

S2k Guidelines for the diagnosis and treatment of chronic pruritus – update – short version

Cross‐European validation of the ItchyQoL in pruritic dermatoses

Contact Info

Product

Resources

About